Inventaire - je vrienden en communities zijn je beste bibliotheek

The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies

auteur

Pere-Joan Cardona i Iglesias

1967 -

Cristina Vilaplana

gepubliceerd in: Frontiers in Microbiology

publicatiedatum: 2014-02-14

belangrijk thema: tuberculose

Cites articles 71

Date

Titel

Auteurs

2013-12-02

Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review

Helen McIlleron, Graeme Meintjes, Stephen Lawn, Robin Wood, Anthony D Harries
2013-08-15

Capacity of lung stroma to educate dendritic cells inhibiting mycobacteria-specific T-cell response depends upon genetic susceptibility to tuberculosis

Alexander S Apt
2013

Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients

Perumal Venkatesan
2013-05-01

Active case finding for tuberculosis among high-risk groups in low-incidence countries

Ibrahim Abubakar
2013-09-19

Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis.

Cristina Vilaplana, Pere-Joan Cardona i Iglesias
2013-04-05

Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis.

Pere-Joan Cardona i Iglesias, Cristina Vilaplana
2013-04-05

Nonsteroidal Antiinflammatory Drugs for Adjunctive Tuberculosis Treatment

Alimuddin Zumla
2012-12-01

IL-17 and IFN-γ production in peripheral blood following BCG vaccination and Mycobacterium tuberculosis infection in human
2012-03-29

Adjunct immunotherapies for tuberculosis

Alimuddin Zumla, Markus Maeurer
2012-01-03

Low dose aerosol fitness at the innate phase of murine infection better predicts virulence amongst clinical strains of Mycobacterium tuberculosis

Pere-Joan Cardona i Iglesias, Clara Prats, Cristina Vilaplana, Sofía Samper
2012-10-22

The recombinant tuberculosis vaccine rBCG ΔureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells.

Stefan Kaufmann
2011-12-18

Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes

James Galagan, Iñaki Comas, Graham Rose, Sébastien Gagneux, Midori Kato-Maeda
2011-11-15

Neutrophils in tuberculosis: friend or foe?

Robert J Wilkinson, Anne O'Garra
2011-08-31

Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae

Pere-Joan Cardona i Iglesias, Sergio López, Bernat Perez de Val, H. Martin Vordermeier
2011-03-13

A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis

Pere-Joan Cardona i Iglesias
2011-03-01

The secret trumps, impelling the pathogenicity of tubercle bacilli

Pere-Joan Cardona i Iglesias
2011-07-25

Impaired fitness of Mycobacterium tuberculosis resistant isolates in a cell culture model of murine macrophages

Pere Coll, Fernando Alcaide, Emma Rey-Jurado, Griselda Tudó
2010-08-19

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

Jacques Banchereau
2010-08-18

Field evaluation of the efficacy of Mycobacterium bovis bacillus Calmette-Guerin against bovine tuberculosis in neonatal calves in Ethiopia

Abraham Aseffa, Gobena Ameni, H. Martin Vordermeier
2010-06-21

Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice
2010-04-06

Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs

Cristina Vilaplana, Ivan Díaz, Pere-Joan Cardona i Iglesias
2010-01-05

Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease

Pere-Joan Cardona i Iglesias
2009-10-26

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

Clifton E Barry, Thomas Dick, Robert J Wilkinson, Dirk Schnappinger, Sabine Ehrt, Veronique Dartois
2009-11-01

Determinants of regional ventilation and blood flow in the lung
2009-04-15

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques

Sarah C Gilbert, Brigitte Gicquel, Carlos Martín, Adrian V. S. Hill, Edmond J Remarque, Helen McShane, Frank A. W. Verreck, Richard A. W. Vervenne, Ivanela Kondova, Klaas W. van Kralingen, Gerco Braskamp, Ariena Kersbergen, Tom H M Ottenhoff, Alan W Thomas
2009-03-23

A dynamic reinfection hypothesis of latent tuberculosis infection

Pere-Joan Cardona i Iglesias
2009-01-01

Cell-mediated immune responses in tuberculosis

Andrea M. Cooper
2009-06-01

Effectiveness and safety of a treatment regimen based on isoniazid plus vaccination with Mycobacterium tuberculosis cells' fragments: field-study with naturally Mycobacterium caprae-infected goats

Emmanuel Serrano, Cristina Vilaplana, E Guirado
2008-07-01

Innate immunity in tuberculosis: myths and truth

Daniel Korbel, Ulrich E Schaible
2008-02-20

Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis

David M. Tobin, Lalita Ramakrishnan
2008-02-07

Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas

Antonio Rothfuchs, Jackson Egen, Carl G Feng, Nathalie Winter, Alan Sher, Ronald N. Germain
2008-02-04

Long term efficacy of DOTS regimens for tuberculosis: systematic review

Helen Cox

Artike - wd:Q38193087

Welcome to Inventaire

de bibliotheek van je vrienden en communities

meer leren